Projects

Project area A focuses on the elucidation of innate and adaptive mechanisms related to the etiology, onset and course of chronic neuroinflammation.

While projects A1-A3 study principal processes of the immune response, projects A4-A6 mainly investigate the initiating (or perpetuating) adaptive immune factors in the disease, and A7-A9 focus on the balance of different adaptive immune responses. Important intracellular functions (A3) as well as antigen recognition (A4-A6) and differentiation or shaping of relevant pro-inflammatory or regulatory lymphocyte subpopulations (A7-A9) are in the center of these projects. Developing the human immune system, in particular the role of lymphocytes, in rodents (A9) will enable us to better achieve our goal of clinical translation.

To learn more about the individual projects, please visit the Project area A page.

Logo-SFB_Bilder-Projects-bilder_1

Project Area B addresses significant processes related to transmigration and infiltration of immune cells into the CNS as well as lesion development, lesion resolution and the impact for the overall functional outcome. These approaches often combine molecular and cellular mechanisms with innovative imaging tools, both in rodent experimental systems and in humans.

Projects B1-B3 investigate the routes of the immune cells and the involved processes at and beyond the blood brain barrier. From there project B4 goes on to the perivascular space and studies antigen-presenting cells (APC) and their capacity to shape the T cell response within the CNS. Project B5 and B6 study an inflammatory lesion and its impact on neuronal network and functional outcome. While project B5 examines this part of the pathology in patients with Multiple Sclerosis using a combination of imaging and advanced electrophysiology, project B6 investigates it in brain slices and rodent models. Projects B7 and B8 study processes of de- and remyelination, also analyzing underlying causes for demyelinated and remyelinated lesions in patients. Processes of neuronal injury as well as the regenerative capacity in the neuronal compartment are investigated in the projects B9 and B10.

To learn more about the individual projects, please visit the Project area B page.

Logo-SFB_Bilder-Projects-bilder_2

Project Area Z consists of a Clinical Translation Unit. The overall aim of this platform is to support various translational aspects of the CRC128. In particular, we pursue the following approaches:

  • Provide a platform for „proof-of-concept“ clinical studies (association with project A08)
  • Present a translational platform for support of single scientific projects in order to strengthen their translational aspects (examples are A01, A08, A09, B03, B07)
  • Provide a service platform in terms of infrastructure as well as biomaterial collection for use in individual scientific projects (examples are A08, A09, A10, B01, B08)

Schematic presentation of assays and methods provided within the CTU

To learn more about the individual projects, please visit the Project area Z page.

News

Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more
Wed, 20/01/2021
A new study on neurological manifestations of severe COVID-19 reveals nervous system immune deficiency
Patients suffering from COVID-19 can develop concomitant and long-term symptoms in their nervous system. The most common symptom in this context is the loss of the sense of smell and taste, while more severe symptoms such as stroke, cerebral seizures, or meningitis are possible. A team of scientists from the medical faculties at the Universities […]...more
Fri, 15/01/2021
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity
It has long been acknowledged that multiple sclerosis disease risk is associated with reduced sun-exposure, and subsequent low vitamin D levels. The study by Ostkamp et al. now assessed the relationship between measures of sun exposure and MS severity. For this, the researchers analyzed data of around 2,000 patients from the German NationMS- and the […]...more